C, S., R, B., A, J., H, B., S, X., Y, W., . . . JS, M. (2018). Cardiotoxicity associated with carfilzomib: Systematic review and meta-analysis. Leukemia & lymphoma, 59(11), 2557. https://doi.org/10.1080/10428194.2018.1437269
Chicago Style (17th ed.) CitationC, Shah, Bishnoi R, Jain A, Bejjanki H, Xiong S, Wang Y, Zou F, and Moreb JS. "Cardiotoxicity Associated with Carfilzomib: Systematic Review and Meta-analysis." Leukemia & Lymphoma 59, no. 11 (2018): 2557. https://doi.org/10.1080/10428194.2018.1437269.
MLA (9th ed.) CitationC, Shah, et al. "Cardiotoxicity Associated with Carfilzomib: Systematic Review and Meta-analysis." Leukemia & Lymphoma, vol. 59, no. 11, 2018, p. 2557, https://doi.org/10.1080/10428194.2018.1437269.
Warning: These citations may not always be 100% accurate.